Rapport
Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions
This document aims to provide interim guidance on the risks for fully vaccinated individuals to develop or transmit infection that will give rise to severe COVID-19 disease in the context of the current epidemiological and vaccine coverage situation in the EU/EEA.
The document assesses the following questions: 1.What is the risk of developing severe COVID-19 for a fully vaccinated individual? 2.What is the risk of severe COVID-19 for an unvaccinated individual in contact with a fully vaccinated person
who has recently been exposed to SARS-CoV-2 infection?
Langues
- Anglais
Année de publication
2021
Type
Rapport
Catégories
- Gestion de programme
Maladies
- COVID-19
Mots-clés
- Suivi de performance
